posaconazole 40 MG/ML Oral Suspension [Noxafil]
posaconazole
RxCUI: 665022
What the CMS Formulary Data Shows for posaconazole 40 MG/ML Oral Suspension [Noxafil]
Per the CMS 2026 Part D formulary file, posaconazole 40 MG/ML Oral Suspension [Noxafil] (RxNorm concept RXCUI 665022, generic name posaconazole) appears on 6 distinct formulary files spanning 38 Medicare Part D plan offerings - 0.7% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.3.
Real-world access to posaconazole 40 MG/ML Oral Suspension [Noxafil] depends on utilization management as much as tier placement: 100% of covering formularies require prior authorization. 0% require step therapy. 16.7% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 8,353 Part D beneficiaries filled posaconazole 40 MG/ML Oral Suspension [Noxafil] in 2023, with total plan-and-beneficiary spending of $79,744,497 and an average per-beneficiary annual cost of $9,546.81. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry posaconazole 40 MG/ML Oral Suspension [Noxafil] today.
Coverage Details
- Formularies covering
- 6
- Plans covering
- 38
- Coverage rate
- 0.7%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 100% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 16.7% of formularies
2023 Medicare Spending
- Beneficiaries
- 8,353
- Total spending
- $79,744,497
- Avg per beneficiary
- $9,546.81
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering posaconazole 40 MG/ML Oral Suspension [Noxafil]
38 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | Yes | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | Yes | $34.50 | NY |
| Health First Rewards H1099-014 (HMO) | HEALTH FIRST HEALTH PLANS | T5 | Yes | $0 | FL |
| Health First SunSaver H1099-016 (HMO) | HEALTH FIRST HEALTH PLANS | T5 | Yes | $0 | FL |
| Health First Complete Care H1099-023 (HMO) | HEALTH FIRST HEALTH PLANS | T5 | Yes | $0 | FL |
| Health First Emerald Plus H1099-024 (HMO) | HEALTH FIRST HEALTH PLANS | T5 | Yes | $0 | FL |
| Health First Premier Access H1099-025 (HMO-POS) | HEALTH FIRST HEALTH PLANS | T5 | Yes | $0 | FL |
| Health First Emerald Plus H1099-026 (HMO) | HEALTH FIRST HEALTH PLANS | T5 | Yes | $0 | FL |
| Health First Premier Access H1099-027 (HMO-POS) | HEALTH FIRST HEALTH PLANS | T5 | Yes | $0 | FL |
| Health First Emerald Plus H1099-028 (HMO) | HEALTH FIRST HEALTH PLANS | T5 | Yes | $0 | FL |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST | T5 | Yes | $0 | NV |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST | T5 | Yes | $0 | NV |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST | T5 | Yes | $0 | NV |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST | T5 | Yes | $0 | NV |
| Prominence Giveback (HMO) | PROMINENCE HEALTHFIRST | T5 | Yes | $0 | NV |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T5 | Yes | $0 | FL |
| Prominence Giveback (HMO) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T5 | Yes | $0 | FL |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $0 | TX |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $0 | TX |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $0 | TX |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $0 | TX |
| Prominence Beyond (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $0 | TX |
| Prominence Giveback (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $0 | TX |
| Prominence Giveback (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $0 | TX |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $0 | TX |
| Prominence Beyond (HMO-POS) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $0 | TX |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T5 | Yes | $0 | FL |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | PROMINENCE HEALTHFIRST | T5 | Yes | $0 | NV |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T5 | Yes | $0 | FL |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $0 | TX |
| Prominence Diabetes and Heart Care Plus (HMO C-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $0 | TX |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $0 | TX |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST | T5 | Yes | $4.20 | NV |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T5 | Yes | $4.80 | FL |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T5 | Yes | $4.80 | TX |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST | T5 | Yes | $9.50 | NV |
| Health First Value H1099-006 (HMO) | HEALTH FIRST HEALTH PLANS | T5 | Yes | $15.00 | FL |
| Health First Classic H1099-001 (HMO-POS) | HEALTH FIRST HEALTH PLANS | T5 | Yes | $49.40 | FL |
Frequently Asked Questions
Is posaconazole 40 MG/ML Oral Suspension [Noxafil] covered by Medicare Part D?
Yes, posaconazole 40 MG/ML Oral Suspension [Noxafil] is covered by 38 Medicare Part D plans (0.7% of all Part D formularies).
What tier is posaconazole 40 MG/ML Oral Suspension [Noxafil] on Medicare Part D plans?
posaconazole 40 MG/ML Oral Suspension [Noxafil] averages Tier 4.3 across Part D plans, ranging from Tier 1 to Tier 5.
Does posaconazole 40 MG/ML Oral Suspension [Noxafil] require prior authorization?
100% of Part D formularies require prior authorization for posaconazole 40 MG/ML Oral Suspension [Noxafil]. Step therapy: 0%. Quantity limits: 16.7%.
How much does Medicare spend on posaconazole 40 MG/ML Oral Suspension [Noxafil]?
In 2023, total Medicare Part D spending on posaconazole 40 MG/ML Oral Suspension [Noxafil] was $79,744,497, covering 8,353 beneficiaries. The average spend per beneficiary was $9,546.81.
Read our methodology - how this data is sourced, computed, and verified.